Heart Transplant Rejection

0
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

One Biosciences
One BiosciencesFrance - Paris
1 program
MMDx diagnostic testN/A1 trial
Active Trials
NCT04707872RecruitingEst. Jul 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
One BiosciencesMMDx diagnostic test

Clinical Trials (1)

NCT04707872One BiosciencesMMDx diagnostic test

Trifecta-Heart cfDNA-MMDx Study

Start: Jun 2021Est. completion: Jul 2027
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space